The beneficial effect of N-acetylcysteine and ciprofloxacin therapy on the outcome of ischemic fulminant hepatic failure

Dig Dis Sci. 2007 Dec;52(12):3507-10. doi: 10.1007/s10620-006-9594-2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acetylcysteine / therapeutic use*
  • Ciprofloxacin / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Free Radical Scavengers / therapeutic use*
  • Humans
  • Ischemia / complications*
  • Ischemia / diagnosis
  • Ischemia / drug therapy
  • Liver / blood supply*
  • Liver Failure, Acute / diagnosis
  • Liver Failure, Acute / drug therapy*
  • Liver Failure, Acute / etiology
  • Male
  • Middle Aged
  • Nucleic Acid Synthesis Inhibitors / therapeutic use*

Substances

  • Free Radical Scavengers
  • Nucleic Acid Synthesis Inhibitors
  • Ciprofloxacin
  • Acetylcysteine